MIS-C patients who were reinfected with SARS-CoV-2. Report of 2 cases

Area of Science:

• Pediatric infectious diseases
• Immunology
• Viral pathogenesis

Background:

• Multisystem Inflammatory Syndrome in Children (MIS-C) is a rare but serious post-infectious complication associated with SARS-CoV-2.
• The long-term immunity and risk of recurrence in children who have recovered from MIS-C following subsequent SARS-CoV-2 infections remain largely unknown.
• Understanding reinfection dynamics is crucial for managing pediatric health during the ongoing pandemic.

Observation:

• This case series reports on two pediatric patients previously diagnosed with MIS-C.
• Both patients experienced documented SARS-CoV-2 reinfection after their initial MIS-C diagnosis.
• Neither patient exhibited signs or symptoms suggestive of MIS-C recurrence during the subsequent infections.

Findings:

• The study observed that children who had recovered from MIS-C did not develop recurrent MIS-C upon reinfection with SARS-CoV-2.
• This suggests that prior MIS-C may confer some level of protection against its recurrence, even with new viral exposure.
• The findings contribute to the understanding of immune responses following MIS-C and SARS-CoV-2 reinfection in children.

Implications:

• These findings suggest that MIS-C recurrence may not be a significant concern for children reinfected with SARS-CoV-2.
• Further research is warranted to elucidate the immunological mechanisms underlying this observed protection.
• This information can help guide clinical management and parental counseling regarding readmission risks for children with a history of MIS-C.